Should I apply for a grant, a loan or investment?
These three instruments solve different problems and impose different obligations. The right answer follows from the project, not the founder's preference.
Key takeaway
These three instruments solve different problems and impose different obligations. The right answer follows from the project, not the founder's preference. This guide weighs British Patient Capital, Help to Grow: Management, Innovate UK Smart Grants against your stage, funding type and timeline using verified FundingAtlas data, and explains when each is the right call.
The question
These three instruments solve different problems and impose different obligations. The right answer follows from the project, not the founder's preference.
Key considerations
The factors that should shape your decision before you commit operator hours to an application.
| Funding stage | growth, any |
|---|---|
| Funding type | equity, other, grant |
| Funding amount | British Patient Capital: Funding levels vary and should be confirmed through the official scheme guidance. • Help to Grow: Management: Funding levels vary and should be confirmed through the official scheme guidance. • Innovate UK Smart Grants: £100k–£2m • Knowledge Transfer Partnership (KTP): ~50–67% of project costs |
| Eligibility | High-growth UK companies backed by funds in the British Patient Capital portfolio. No direct applications. |
| Timeline | There is no central British Patient Capital application. Engagement with each underlying fund typically runs 3–9 months from first meeting to term sheet, plus a further 4–12 weeks of diligence and legals to close. Plan investor processes well in advance of when you need the cash. |
| Region | Some programmes are England-only, others run across the devolved nations or are restricted to combined-authority footprints. Check each official source. |
Recommended route
## Quick Answer Grants suit innovation work with technical risk and weak short-term commercial proof. Loans suit projects that will generate enough cash to service repayments. Investment suits businesses that need significant capital and are willing to dilute ownership for scale. Most growing businesses use a mix over time.
## Typical Situation A founder or finance lead weighing the next capital decision — often after a successful early period — and unsure which instrument fits.
## Advisor Interpretation The choice is rarely "cheapest money". Each instrument prices a different risk: grants price novelty, loans price repayment capacity, investment prices growth and exit. Choosing the wrong instrument for the project usually fails — not because the project is bad, but because it cannot meet the underwriting test that instrument requires.
## Readiness Signals - Grants: defined R&D problem, novelty, team, match funding. - Loans: forecastable cashflow, ability to service debt, security or covenant capacity. - Investment: scale narrative, governance readiness, willingness to dilute and report.
## Common Mistakes - Choosing the instrument by who shouts loudest, not by project fit. - Mixing grant and equity work on the same activity without checking subsidy rules. - Raising equity for what is really an R&D project that a grant would have funded.
## Usually Too Early When You cannot answer "what is this capital actually for?" in one sentence; you cannot meet the basic underwriting test for the instrument you are pursuing.
## What Usually Comes Next A clear project definition usually points to one obvious instrument, with the others sequenced behind it. Innovation-led growth typically moves through grant → loan/equity → consortium R&D.
## Related Comparisons - /comparisons/smart-grants-vs-innovation-loans - /comparisons/start-up-loans-vs-angel-investment - /comparisons/british-patient-capital-vs-venture-capital
## Related Pathways - /pathways/startup - /pathways/scale-up
## Conservative Note All three routes have legal, tax and subsidy implications. Always take independent advice before committing.
Alternative routes
Where the primary recommendation is not the right fit, these are the programmes most commonly considered alongside it.
- Help to Grow: Management
other · Funding levels vary and should be confirmed through the official scheme guidance.
- Innovate UK Smart Grants
grant · £100k–£2m
- Knowledge Transfer Partnership (KTP)
grant · ~50–67% of project costs
Common mistakes
- Starting with the largest scheme rather than the highest-fit scheme.
- Treating funding as a one-off project rather than a 24-month strategy.
- Underestimating the documentation effort: prior trading, prior R&D, finance pack.
- Missing the interaction between grant income and downstream R&D tax relief.
- Engaging a contingent-fee broker before checking whether the scheme is broker-eligible.
- Self-selecting out of a programme based on an optimistic read of eligibility.
Decision checklist
- Confirm your business stage, region and headcount against scheme thresholds.
- Map the next 24 months of funding need before applying to any one programme.
- Identify the official source for each programme on your shortlist.
- Quantify match-funding and staged-drawdown impact on cashflow.
- Check subsidy-control / de minimis ceilings across stacked awards.
- Model the interaction with R&D tax relief on subsidised costs.
- Decide whether the assessment timeline fits your delivery plan.
- Schedule the application in the calendar before committing operator hours.
Frequently asked questions
- What is this decision guide about?
- These three instruments solve different problems and impose different obligations. The right answer follows from the project, not the founder's preference.
- Which funding stage does this guide cover?
- Programmes referenced here target: growth, any.
- What types of funding are compared?
- This guide considers: equity, other, grant.
- How much funding could I access?
- British Patient Capital: Funding levels vary and should be confirmed through the official scheme guidance.. Help to Grow: Management: Funding levels vary and should be confirmed through the official scheme guidance.. Innovate UK Smart Grants: £100k–£2m. Knowledge Transfer Partnership (KTP): ~50–67% of project costs.
- Who is eligible for the recommended routes?
- High-growth UK companies backed by funds in the British Patient Capital portfolio. No direct applications.
- How long will it take to receive funding?
- There is no central British Patient Capital application. Engagement with each underlying fund typically runs 3–9 months from first meeting to term sheet, plus a further 4–12 weeks of diligence and legals to close. Plan investor processes well in advance of when you need the cash.
- Can I apply to more than one of these programmes?
- Some combinations are permitted, others are restricted by subsidy-control rules or scheme-specific exclusivity clauses. Refer to the latest programme guidance before stacking applications.
- Will receiving a grant affect my R&D tax relief claim?
- It can. Grant-subsidised R&D expenditure is often relievable only at a reduced rate, and the interaction depends on which scheme funded which costs. FundingAtlas could not verify the interaction for every combination; confirm with a qualified adviser.
- What if my situation does not match any of the recommended routes?
- Use the Funding Finder to build a personalised shortlist, or request a Funding Strategy Review for a reviewer-led assessment.
- Where do I find the official source for each programme?
- British Patient Capital: https://www.britishpatientcapital.co.uk/our-portfolio/ — Help to Grow: Management: https://smallbusinesscharter.org/help-to-grow-management/ — Innovate UK Smart Grants: https://apply-for-innovation-funding.service.gov.uk/competition/search — Knowledge Transfer Partnership (KTP): https://www.ktp-uk.org/
Next steps
More decision guides